Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NMDAE for Cognitive Impairment and Perceived Stress in Bipolar I Disorder
NCT05977023Phase 2Recruiting
- Sponsor
- China Medical University Hospital
- Start
- Oct 2023
- Primary completion
- Nov 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sodium benzoate in bipolar I disorder, sponsored by China Medical University Hospital. Started Oct 2023; status: recruiting.
02
Drugs
sodium benzoate
03
Conditions
bipolar I disorder
Beyond the preview
Go deeper on NCT05977023.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05977023.